Cargando…
Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1
Autores principales: | Das, Andrew B., Kakadia, Purvi M., Wojcik, Damian, Pemberton, Lucy, Browett, Peter J., Bohlander, Stefan K., Vissers, Margreet C. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775073/ https://www.ncbi.nlm.nih.gov/pubmed/31578317 http://dx.doi.org/10.1038/s41408-019-0242-4 |
Ejemplares similares
-
Efficient identification of somatic mutations in acute myeloid leukaemia using whole exome sequencing of fingernail derived DNA as germline control
por: Kakadia, Purvi M., et al.
Publicado: (2018) -
Emerging epigenetic therapeutics for myeloid leukemia: modulating demethylase activity with ascorbate
por: Das, Andrew B., et al.
Publicado: (2020) -
Ascorbate Inhibits Proliferation and Promotes Myeloid Differentiation in TP53-Mutant Leukemia
por: Smith-Díaz, Carlos C., et al.
Publicado: (2021) -
TET2/IDH1/2/WT1 and NPM1 Mutations Influence the RUNX1 Expression Correlations in Acute Myeloid Leukemia
por: Pasca, Sergiu, et al.
Publicado: (2020) -
Context dependent effects of ascorbic acid treatment in TET2 mutant myeloid neoplasia
por: Guan, Yihong, et al.
Publicado: (2020)